Author:
Alaqel Saleh I.,Alqahtani Arwa S.,Alharbi Adnan,Althobaiti Yusuf S.,Bamaga Ahmed K.,Algarni Majed A.,Almrasy Ahmed A.,Almalki Atiah H.
Abstract
AbstractAutism spectrum disorder is a significant concern worldwide, particularly in Middle Eastern countries. Aripiprazole, a psychiatric medicine that works as a partial agonist at D2 receptors, is often used for autism-related behavior issues in children. Monitoring the therapy of aripiprazole could enhance the safety and effectiveness of treatment for autistic individuals. The purpose of this study was to develop a highly sensitive and environmentally friendly method for analysis of aripiprazole in plasma matrix. To achieve this, water-soluble N-carbon quantum dots were produced from a natural green precursor, guava fruit, and used in fluorescence quenching spectroscopy to determine the presence of aripiprazole. The synthesized dots were analyzed and characterized using transmission electron microscopy and Fourier transform infrared spectroscopy, and they showed a strong fluorescence emission peak at 475 nm. The proposed method was validated according to ICH M10 guidelines and was shown to be highly sensitive, allowing for nanoscale determination of aripiprazole in plasma matrix. Additionally, the method was compared to a previously reported spectrophotometric method, and it was found to be more sensitive and consistent with the principles of green analytical chemistry.
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Lord, C. et al. Autism from 2 to 9 years of age. Arch. Gen. Psychiatry 63, 694–701. https://doi.org/10.1001/archpsyc.63.6.694 (2006).
2. Hyman, S. L. et al. Identification, evaluation, and management of children with autism spectrum disorder. Pediatr. 145, e20193447. https://doi.org/10.1542/peds.2019-3447 (2020).
3. Centers for disease control and prevention, autism spectrum disorder (ASD). https://www.cdc.gov/ncbddd/autism/facts.html#:~:text=Autism%20spectrum%20disorder%20(ASD)%20is,most%20common%20ways%20people%20develop. (accessed 31 March 2022).
4. Schworer, E. K., Ahmed, A., Hogenkamp, L., Moore, S. & Esbensen, A. J. Associations among co-occurring medical conditions and cognition, language, and behavior in Down syndrome. Res. Dev. Disabil. 126, 104236. https://doi.org/10.1016/j.ridd.2022.104236 (2022).
5. Tanner, A. & Dounavi, K. The emergence of autism symptoms prior to 18 months of age: A systematic literature review. J. Autism Dev. Disord. 51, 973–993. https://doi.org/10.1007/s10803-020-04618-w (2021).